圣地亚哥2024年1月17日 /美通社/ –作为开发首款帕金森病 (PD) 的自体神经元替代疗法的私营生物技术公司，Aspen Neuroscience, Inc. 于今日宣布，任命法理学硕士 Ana Sousa 为公司首席合规官。 Sousa 女士自 2021 年以来始终担任 Aspen 的监管和质量高级副总裁。其在任职期间创建了监管、质量和项目管理团队，并担任 ANPD001 项目团队负责人，负责指导战略，并致力于推动主导产品从临床前阶段到临床阶段。 “Ana 作为执行团队的关键成员，在我们组织的构建和推动主要治疗候选药物进入临床方面发挥了关键作用，”Aspen Neuroscience 总裁兼首席执行官 Damien…

LOGAN, Utah, Jan. 16, 2024 /PRNewswire/ — Cyrusher, a leading manufacturer of electric mobility vehicles and other devices, recently presented its…

XINTAI, China, Jan. 17, 2024 /PRNewswire/ — As one of the largest dairy and milk consumers in the world, with…

NOIDA, Inde, 17 janvier 2024 /PRNewswire/ — PureSoftware a été certifié Great Place to Work® en Inde (de janvier 2024 à janvier 2025)…

NEW YORK, Jan. 17, 2024 /PRNewswire/ — The ultraviolet (UV) disinfection equipment market is estimated to grow by USD 788.3 million from 2022 to…

DUBLIN, Jan. 16, 2024 /PRNewswire/ — The “Europe Space-Based Laser Communication Market – Analysis and Forecast, 2023-2033” report has been added to ResearchAndMarkets.com’s…

NEW YORK, Jan. 16, 2024 /PRNewswire/ — The wind turbine gearbox market size is expected to grow by USD 4.23 billion…

Leading Property Management Franchise Bolsters Tech Stack to Empower Operators with Best-in-Class PMS Software BROOMFIELD, Colo., Jan. 16, 2024 /PRNewswire/…

CANTON, Ohio, Jan. 17, 2024 /PRNewswire/ — The popularity and use of artificial intelligence (AI) in real estate has become…